Bottom line
FHLC vs SCHLX: the short answer
FHLC (Fidelity MSCI Health Care Index ETF) and SCHLX (DWS Health and Wellness Fund) share a meaningful slice of their top holdings — about 81% by weight.
But FHLC is far broader, holding 337 positions to 65 for SCHLX, so beyond the top names it adds exposure SCHLX doesn't have.
FHLC is cheaper at 0.084% vs 1.06% — a difference of $98 a year per $10,000 invested.
Updated Nov 19, 2026
FHLC vs SCHLX side by side
| FHLC | SCHLX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Fidelity | DWS (Xtrackers) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.084% | 1.06% |
| Annual cost per $10k | $8.4 | $106 |
| 10-yr cost on $10k (prospectus) | $108 | $1,294 |
| Max front load | None | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +2.6% | — |
| 5-yr return (annualized) | +7.2% | — |
| 10-yr return (annualized) | +8.8% | — |
| Best quarter | +16.4% | — |
| Worst quarter | −13.1% | — |
| Net assets (fund) | $3.3B | $231.8M |
| Number of holdings | 337 | 65 |
| Portfolio turnover | 3% | 2% |
| Returns as of | Nov 30, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
21 of FHLC's top 25 holdings also appear in SCHLX's top 25.
| Holding | FHLC | SCHLX |
|---|---|---|
| Eli Lilly & Co | 13.35% | 13.85% |
| Johnson & Johnson | 8.93% | 6.19% |
| AbbVie Inc | 6.42% | 4.90% |
| UnitedHealth Group Inc | 5.44% | 5.73% |
| Merck & Co Inc | 4.66% | 4.85% |
| Thermo Fisher Scientific Inc | 3.09% | 3.46% |
| Amgen Inc | 3.00% | 2.88% |
| Abbott Laboratories | 2.66% | 2.39% |
| Gilead Sciences Inc | 2.34% | 2.78% |
| Pfizer Inc | 2.06% | 1.17% |
| Bristol-Myers Squibb Co | 1.93% | 1.50% |
| Intuitive Surgical Inc | 1.82% | 2.69% |
| Danaher Corp | 1.80% | 2.13% |
| Vertex Pharmaceuticals Inc | 1.76% | 2.45% |
| Stryker Corp | 1.62% | 2.61% |
Source: SEC Form N-PORT
FHLC top 10
- Eli Lilly & Co — 13.35%
- Johnson & Johnson — 8.93%
- AbbVie Inc — 6.42%
- UnitedHealth Group Inc — 5.44%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 3.09%
- Amgen Inc — 3.00%
- Abbott Laboratories — 2.66%
- Gilead Sciences Inc — 2.34%
- Pfizer Inc — 2.06%
SCHLX top 10
- Eli Lilly & Co — 13.85%
- Johnson & Johnson — 6.19%
- UnitedHealth Group Inc — 5.73%
- AbbVie Inc — 4.90%
- Merck & Co Inc — 4.85%
- AstraZeneca PLC — 3.80%
- Thermo Fisher Scientific Inc — 3.46%
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
FAQ
What is the difference between FHLC and SCHLX?
Which is cheaper, FHLC or SCHLX?
Should I own both FHLC and SCHLX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.